跳到正文
原文
Medical Xpress·· 16 天前精选AI 评分70

三分之一婴儿的花生过敏诊断被移除

A third of babies have peanut allergy diagnosis removed

AI 导读

一项由默德儿童研究学院和澳大利亚国家过敏卓越中心主导的研究发现,三分之一被怀疑有花生过敏的婴儿在口服食物挑战中未出现反应,这表明他们可能不需要长期避免花生。研究强调了确诊前进行口服食物挑战的重要性,有助于减少儿童及其家庭的负担。

推荐理由

研究揭示了大量婴儿被误诊为花生过敏,强调了确诊前进行口服食物挑战的重要性。

正文
baby eating
Credit: Andrea Piacquadio from Pexels

A world-first national program has discovered more than a third of babies thought to have a peanut allergy could safely have the diagnosis removed. And the findings are changing how Australia's health care system approaches infant food allergies.

The research, led by Murdoch Children's Research Institute (MCRI) and the National Allergy Centre of Excellence (NACE) in partnership with 10 pediatric public hospitals across Australia, found 35% of infants with a recent reaction to peanut and a positive allergy test didn't react during an oral food challenge. Without the challenge, these children would have likely continued to avoid peanut in case they triggered an allergic reaction.

MCRI Population Allergy Group senior research clinician and ADAPT medical lead Dr. Tim Brettig said the study highlighted the importance of confirming a peanut allergy before committing children to long-term treatment.

"We found more than one third of infants who were suspected to have peanut allergy based on their history and initial tests no longer reacted when they underwent a supervised food challenge," he said. "Being able to identify those children early allows them to avoid an unnecessary allergy label and the burden of avoiding peanut."

The findings form part of a study evaluating the ADAPT Peanut Oral Immunotherapy Program, which was launched in 2024 by the NACE, hosted at MCRI. ADAPT is the first peanut allergy treatment program offered in Australian public hospitals for infants outside of a clinical trial setting.

As part of this evaluation, 1,275 infants under 18 months old were assessed, with 778 undergoing an oral food challenge. The infants presented at participating hospitals across Victoria, New South Wales, Queensland, South Australia and Western Australia. During a food challenge, infants receive increasing doses of peanut under medical supervision to check for an allergic reaction.

The study, published in The Journal of Allergy and Clinical Immunology: In Practice, found that while 65% of babies had a reaction, including 12% who experienced anaphylaxis, all episodes were safely managed by the teams conducting the food challenges.

The 35% who had no reaction were considered peanut tolerant and could have their allergy label removed, allowing them to regularly eat peanut in an age-appropriate form, such as peanut butter.

Almost all babies who reacted proceeded to peanut oral immunotherapy, a treatment involving daily doses of peanut to build tolerance, with 97.5% successfully starting treatment at a dose guided by their challenge results.

Australia has some of the highest reported rates of childhood food allergies in the world, with peanut allergy affecting about one in 30 children.

MCRI Population Allergy Group leader and NACE director Kirsten Perrett, also the ADAPT program lead, said the results had implications for how peanut allergy was managed in Australia.

"Oral food challenges are not currently used routinely for every infant with suspected peanut allergy," she said. "But our results show that clinical history and allergy testing alone were not enough to accurately diagnose peanut allergy in many cases. A supervised oral food challenge should be routinely considered to confirm the diagnosis before an infant starts oral immunotherapy.

"With peanut allergy one of the most common childhood food allergies, it's particularly important that we have an accurate diagnosis when a baby first shows signs of a possible peanut allergy. We want to reduce the burden of food allergy for children and their families, and the ADAPT Program is a step in this direction."

When Leah and Jake introduced their infant son to peanuts, the reaction was almost immediate.

Just 5 months old at the time, Arthur's face reddened and hives appeared on his shoulders and under his nose. The reaction settled within an hour, but the family was left unsure as to whether Arthur had a peanut allergy.

"Our GP referred us to an allergy specialist who took skin prick and blood tests," Leah said. "The results suggested Arthur had a high risk of reacting to peanut, and we were advised to avoid it while we awaited further tests."

Arthur, now 1 year old, was referred to the ADAPT Program at The Royal Children's Hospital (RCH). Despite his earlier side effects and allergy test results, Arthur tolerated the supervised oral food challenge without reacting. His suspected peanut allergy label was removed.

"We were understandably anxious going into the challenge, because we didn't know how Arthur would respond," Leah said.

"It's a huge relief knowing Arthur can tolerate peanut and we can move forward without the uncertainty of managing a suspected allergy. Having the opportunity to find out he could tolerate peanuts has made a real difference to our family."

Needing to travel to Melbourne for the food challenge, Leah hopes more families, particularly those in regional and remote areas, will have similar opportunities to clarify their child's diagnosis.

If families suspect their baby has a peanut allergy, they are encouraged to talk to their GP, who might refer them to a pediatric allergy specialist.

More information

Tim W. Brettig et al., An Oral Food Challenge Is Required for Accurate Diagnosis of Peanut Allergy in Infants Prior to Oral Immunotherapy: Evaluation of the Allergy Development to an Accelerated Pathway to Tolerance Peanut Oral Immunotherapy Program, The Journal of Allergy and Clinical Immunology: In Practice (2026). DOI: 10.1016/j.jaip.2026.08.044

Who's behind this story?

Gaby Clark

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: A third of babies have peanut allergy diagnosis removed (2026, November 4) retrieved 4 November 2026 from https://medicalxpress.com/news/2026-11-babies-peanut-allergy-diagnosis.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com